Ascorbic acid in idiopathic recurrent calcium urolithiasis in humans - does it have an abettor role in oxalate, and calcium oxalate crystallization?

Schwille, P. O.; Schmiedl, A.; Herrmann, U.; Manoharan, M.; Fan, Jie; Sharma, Vikas; Gottlieb, David

doi:10.1007/s002400000101

Cited by 9 publications

(2 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In addition, Schwille et al. showed that ascorbic acid load does not stimulate urinary calcium oxalate supersaturation and crystallisation in patients with idiopathic calcium oxalate urolithiasis.…”

Section: Discussionmentioning

confidence: 99%

Oxalate at physiological urine concentrations induces oxidative injury in renal epithelial cells: effect of α‐tocopherol and ascorbic acid

2014

View full text Add to dashboard Cite

ObjectivesTo test our hypothesis that physiological levels of urinary oxalate induce oxidative renal cell injury, as studies to date have shown that oxalate causes oxidative injury only at supra-physiological levels. To study the combined effect of α-tocopherol and ascorbic acid against oxalate-induced oxidative injury, as oxalate-induced oxidative cell injury is known to promote initial attachment of calcium oxalate crystals to injured renal tubules and subsequent development of kidney stones. Materials and MethodsCultures of normal (antioxidant-undepleted) and antioxidant-depleted LLC-PK1 cells were exposed to oxalate at human physiological urine concentrations. After exposure, markers of oxidative stress and cell injury were measured in the cells and media, respectively. In addition, we also evaluated the combined effects of α-tocopherol and ascorbic acid on oxalate-induced oxidative cell injury. ResultsExposure of renal cells to oxalate at urinary physiological levels increased the oxidative cell injury as assessed by increased lactate dehydrogenase (LDH) leakage and increased lipid hydroperoxide in the renal cells; however, this effect was not seen until 24 h after oxalate exposure, at which point the injury was milder. On the other hand, when cellular reduced glutathione (GSH) and catalase were depleted in renal epithelial cells with pharmacological inhibitors, the physiological levels of urinary oxalate caused significant oxidative cell injury at 24 h, and remarkably, when additional endogenous antioxidants were depleted, the oxalate at the upper limit of normal 24 h urine caused a significant amount of cell injury in a shorter period of time, which was comparable to that seen in cells exposed to higher levels of oxalate. Exposure of LLC-PK1 cells to oxalate resulted in increased levels of H2O2 and lipid hydroperoxide, correlating with increased release of cell injury markers, including LDH, alkaline phosphate, and γ-glutamyl transpeptidase from renal tubular epithelial cells. Oxalate exposure decreased the activity and protein expression of superoxide dismutase and glutathione peroxidase in a time-dependent manner. LLC-PK1 cells treated with oxalate and either α-tocopherol or ascorbic acid alone exhibited a significant decrease in oxidative cell injury and restored endogenous renal antioxidants towards normal levels, and interestingly, combined treatment with α-tocopherol and ascorbic was more efficient at preventing oxalate-induced toxicity than treatment with either agent alone. ConclusionTo our knowledge this is the first study to show that oxalate alone at human physiological urine concentrations (in the absence of calcium oxalate crystal formation), induced oxidative renal injury in renal epithelial cells when endogenous antioxidants are depleted. Our data further suggests that a combination of α-tocopherol and ascorbic acid may be more effective than each individual agent in reducing oxalate-induced oxidative renal injury and subsequent calcium oxalate crystal deposition in recurrent stone formers.

show abstract

Section: Discussionmentioning

confidence: 99%

Oxalate at physiological urine concentrations induces oxidative injury in renal epithelial cells: effect of α‐tocopherol and ascorbic acid

2014

View full text Add to dashboard Cite

show abstract

“…1 However, the documented effects of excessive amounts of parenteral ascorbic acid on urinary oxalate levels have been equivocal. [2][3][4][5][6][7][8][9][10][11][12][13] Some of the ambiguity is because of heterogeneity of subjects. Patient vari-ables can include non-stone-forming individuals and those with enteric hyperoxaluria.…”

mentioning

confidence: 99%